Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$175M |
| 2 |
Amazon
AMZN
|
+$94.9M |
| 3 |
Evergy
EVRG
|
+$79.1M |
| 4 |
Meta Platforms (Facebook)
META
|
+$61.1M |
| 5 |
Microsoft
MSFT
|
+$56M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWX
Time Warner Inc
TWX
|
+$283M |
| 2 |
MON
Monsanto Co
MON
|
+$197M |
| 3 |
TSMC
TSM
|
+$82.8M |
| 4 |
CSRA
CSRA Inc.
CSRA
|
+$43.5M |
| 5 |
DST
DST Systems Inc.
DST
|
+$37.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.06% |
| 2 | Financials | 14.34% |
| 3 | Healthcare | 12.26% |
| 4 | Industrials | 10.71% |
| 5 | Consumer Discretionary | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2126
Mercantile Bank Corp
MBWM
$1.06B
| $3.94M | ﹤0.01% |
106,584
+33,236
| +45% | +$1.19M |
|
|
ATNX
2127
DELISTED
Athenex, Inc. Common Stock
ATNX
| $3.94M | ﹤0.01% |
10,544
+4,228
| +67% | +$1.45M |
|
|
CIVI
2128
DELISTED
Civitas Resources
CIVI
| $3.93M | ﹤0.01% |
103,706
-431
| -0.4% | -$13.8K |
|
2129
NeoGenomics
NEO
$2.05B
| $3.92M | ﹤0.01% |
299,042
-6,953
| -2% | -$76.5K |
|
2130
German American Bancorp
GABC
$1.95B
| $3.9M | ﹤0.01% |
108,686
+5,542
| +5% | +$197K |
|
|
BNFT
2131
DELISTED
Benefitfocus, Inc.
BNFT
| $3.9M | ﹤0.01% |
115,895
+4,406
| +4% | +$138K |
|
2132
Hamilton Lane
HLNE
$5.12B
| $3.88M | ﹤0.01% |
80,869
+4,249
| +6% | +$187K |
|
2133
Horizon Bancorp
HBNC
$1.06B
| $3.88M | ﹤0.01% |
187,456
+11,657
| +7% | +$238K |
|
2134
Center Bancorp
CNOB
$1.67B
| $3.83M | ﹤0.01% |
153,986
+9,769
| +7% | +$265K |
|
|
VIA
2135
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
| $3.83M | ﹤0.01% |
78,520
+6,167
| +9% | +$332K |
|
2136
Akebia Therapeutics
AKBA
$351M
| $3.82M | ﹤0.01% |
382,512
+36,391
| +11% | +$364K |
|
2137
Camden National
CAC
$1B
| $3.81M | ﹤0.01% |
83,387
+11,057
| +15% | +$501K |
|
2138
Ring Energy
REI
$307M
| $3.79M | ﹤0.01% |
300,438
+33,550
| +13% | +$487K |
|
2139
HealthStream
HSTM
$842M
| $3.79M | ﹤0.01% |
138,723
+14,703
| +12% | +$390K |
|
|
APLS
2140
DELISTED
Apellis Pharmaceuticals
APLS
| $3.79M | ﹤0.01% |
172,179
+129,488
| +303% | +$2.98M |
|
2141
DXP Enterprises
DXPE
$2.49B
| $3.74M | ﹤0.01% |
97,870
+20,233
| +26% | +$779K |
|
|
EPZM
2142
DELISTED
Epizyme, Inc
EPZM
| $3.74M | ﹤0.01% |
275,704
+11,693
| +4% | +$182K |
|
|
MCHB
2143
Mechanics Bancorp
MCHB
$3.78B
| $3.73M | ﹤0.01% |
138,411
+8,282
| +6% | +$228K |
|
2144
Medpace
MEDP
$16.1B
| $3.73M | ﹤0.01% |
86,716
+13,518
| +18% | +$546K |
|
2145
Madrigal Pharmaceuticals
MDGL
$11B
| $3.73M | ﹤0.01% |
13,320
+3,392
| +34% | +$596K |
|
2146
Peoples Bancorp
PEBO
$1.51B
| $3.71M | ﹤0.01% |
98,307
+16,527
| +20% | +$611K |
|
|
ITG
2147
DELISTED
Investment Technology Group Inc
ITG
| $3.71M | ﹤0.01% |
177,566
+9,362
| +6% | +$200K |
|
|
HSKA
2148
DELISTED
Heska Corp
HSKA
| $3.71M | ﹤0.01% |
35,761
+1,367
| +4% | +$128K |
|
2149
Collegium Pharmaceutical
COLL
$1.15B
| $3.71M | ﹤0.01% |
155,374
+104,255
| +204% | +$2.56M |
|
|
DOCU
2150
DocuSign
DOCU
$10.8B
| $3.7M | ﹤0.01% |
+69,885
| New | +$3.53M |
|
Similar funds
Charles Schwab's Q2 2018 Portfolio in Review
As of Q2 2018, Charles Schwab held 3,239 positions worth $137B, up 6.7% from $129B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Charles Schwab deployed $4.16B of net new capital in Q2 2018, opening 167 new positions and adding to 2,358 existing holdings. Its largest new stake was Evergy: 1,477,509 shares worth $83M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was TSMC, an estimated $82.8M trimmed.
- Charles Schwab's largest Q2 2018 buy was Evergy: 1,477,509 shares worth $83M.
- Charles Schwab added most to AT&T in Q2 2018, an estimated $175M increase.
- Charles Schwab's biggest Q2 2018 reduction was TSMC, cutting an estimated $82.8M.
- Charles Schwab fully exited Time Warner Inc in Q2 2018, selling an estimated $283M.
- Charles Schwab's ten largest holdings make up 14% of its $137B portfolio in Q2 2018.
- Charles Schwab opened 167 new positions and closed 125 in Q2 2018.
- Charles Schwab's portfolio value rose 6.7% quarter-over-quarter to $137B.
Based on Charles Schwab's 13F filing for Q2 2018, filed 8 Aug 2018.